Xtant Medical Holdings (XTNT) Liabilities and Shareholders Equity (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Liabilities and Shareholders Equity for 16 consecutive years, with $94.1 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity changed 0.33% year-over-year to $94.1 million; the TTM figure through Dec 2025 stood at $399.8 million (up 4.59% YoY), while the FY2025 annual figure was $94.1 million, changed 0.33% from the prior year.
• Liabilities and Shareholders Equity declined to $94.1 million in Q4 2025 per XTNT's latest filing, from $106.3 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $106.3 million in Q3 2025 and bottomed at $52.7 million in Q2 2022.
• Historically, Liabilities and Shareholders Equity has averaged $77.3 million across 5 years, with a median of $78.6 million in 2023.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 11.67% — and 2023, when it surged 64.15%.
• Xtant Medical Holdings' Liabilities and Shareholders Equity stood at $54.7 million in 2021, then rose by 10.12% to $60.2 million in 2022, then surged by 53.77% to $92.6 million in 2023, then rose by 1.32% to $93.8 million in 2024, then climbed by 0.33% to $94.1 million in 2025.
• Business Quant data shows XTNT's Liabilities and Shareholders Equity at $94.1 million in Q4 2025, $106.3 million in Q3 2025, and $103.5 million in Q2 2025.